London School of Hygiene & Tropical Medicine

Future directions in the evaluation of innovative technologies in healthcare: Technology in healthcare is rapidly advancing. For example, a recent healthcare report suggests that 9 out of 10 operations will be undertaken by robot assisted surgery by 2035. It is also anticipated that artificial intelligence (AI) will soon become much more widespread in the health service and the use of augmented/virtual reality more routinely adopted in clinician training.  Innovations such as surgical technology, AI, and other innovative devices raise complex challenges for evaluation – for example the incorporation of learning curves, ensuring evaluation is possible without slowing down the innovation pathway, evaluating interventions while they are still be refined etc. Evaluation of these innovative technologies also raises statistical design and analysis challenges. This talk will present some of the emerging challenges and opportunities with the evaluation of innovative technologies, highlight a number of relevant frameworks (e.g. IDEAL, CPI-AI) and discuss the role of statistical approaches (such as Bayesian borrowing, learning curves analysis, estimands, etc) that can support evaluation in this space. Future directions in this arena will also be discussed.

Speaker

Professor Marion Campbell

Professor of Health Services Research, Co-Director, Royal College of Surgeons Aberdeen Surgical Trials Centre

Professor Marion Campbell is Professor of Health Services Research at the University of Aberdeen. She is also Director of the Royal College of Surgeons (RCSEngland) Aberdeen Surgical Trials Centre. Marion is a medical statistician by training, a clinical trialist and methodologist. Her main research interests are in the design, conduct and analysis of clinical trials of complex interventions and of surgical, device and critical care trials. She has published widely on clinical trials methodology including on cluster randomised trials, design of trials of surgical interventions, pragmatic trials and trials reporting. She has served on many national and international funding agencies and committees and is an elected Fellow of the Academy of Medical Sciences, the Royal Society of Edinburgh, the Faculty of Public Health, and the International Society for Clinical Trials.

Event notices

• Please note that you can join this event in person or you can join the session remotely
• Please note that the recording link will be listed on this page when available